MMP9 and triple-A syndrome: Notably, transplantation of thoracic PVAT into the abdominal aorta altered abdominal PVAT, inhibiting macrophage infiltration and MMP-9 production, while preventing VSMC apoptosis by promoting adipocyte cartilage oligomeric matrix protein release, ultimately reducing AAA formation (Huang et al., 2023).